IDEAS home Printed from https://ideas.repec.org/
MyIDEAS: Login

Citations for " The Changing Rewards to Science: The Case of Biotechnology"

by Stephan, Paula E & Everhart, Stephen S

For a complete description of this item, click here. For a RSS feed for citations of this item, click here.
as in new window

  1. Michael S. Lawlor, 2003. "Biotechnology and government funding: economic motivation and policy models," Proceedings, Federal Reserve Bank of Dallas, issue Sep, pages 131-146.
  2. Nicolaou, Nicos & Birley, Sue, 2003. "Academic networks in a trichotomous categorisation of university spinouts," Journal of Business Venturing, Elsevier, vol. 18(3), pages 333-359, May.
  3. Timothy F. Howe, 2003. "Financing biotechnology research: a firsthand perspective," Proceedings, Federal Reserve Bank of Dallas, issue Sep, pages 119-130.
  4. Corolleur, Catherine D. F. & Carrere, M. & Mangematin, V., 2004. "Turning scientific and technological human capital into economic capital: the experience of biotech start-ups in France," Research Policy, Elsevier, vol. 33(4), pages 631-642, May.
  5. Chok, Jay Inghwee, 2009. "Regulatory dependence and Scientific Advisory Boards," Research Policy, Elsevier, vol. 38(5), pages 710-725, June.
  6. David Catherine & Frédéric Corolleur & Myriam Carrère & Vincent Mangematin, 2004. "Turning scientific and technological human capital into economic capital: the experience of biotech start-ups in France," Grenoble Ecole de Management (Post-Print) hal-00422583, HAL.
  7. Lam, Alice, 2011. "What motivates academic scientists to engage in research commercialization: ‘Gold’, ‘ribbon’ or ‘puzzle’?," Research Policy, Elsevier, vol. 40(10), pages 1354-1368.
  8. Ding, Waverly & Choi, Emily, 2011. "Divergent paths to commercial science: A comparison of scientists' founding and advising activities," Research Policy, Elsevier, vol. 40(1), pages 69-80, February.
  9. Luo, Xiaowei Rose & Koput, Kenneth W. & Powell, Walter W., 2009. "Intellectual capital or signal? The effects of scientists on alliance formation in knowledge-intensive industries," Research Policy, Elsevier, vol. 38(8), pages 1313-1325, October.
  10. John V. Duca & Mine K. Yücel, 2003. "Science and Cents: Exploring the economics of biotechnology: an overview," Proceedings, Federal Reserve Bank of Dallas, issue Sep, pages 3-10.
  11. Michael R. Darby & Lynne G. Zucker, 2002. "Going Public When You Can in Biotechnology," NBER Working Papers 8954, National Bureau of Economic Research, Inc.
  12. Lynne G. Zucker & Michael R. Darby & Jeff S. Armstrong, 2003. "Commercializing knowledge: university science, knowledge capture and firm performance in biotechnology," Proceedings, Federal Reserve Bank of Dallas, issue Sep, pages 149-170.
  13. Michael R. Darby & Lynne G. Zucker, 2003. "Growing by Leaps and Inches: Creative Destruction, Real Cost Reduction, and Inching Up," Economic Inquiry, Western Economic Association International, vol. 41(1), pages 1-19, January.
  14. Tetsugen Haruyama, 2009. "Competitive Innovation With Codified And Tacit Knowledge," Scottish Journal of Political Economy, Scottish Economic Society, vol. 56(s1), pages 390-414, 09.
  15. Henry G. Grabowski, 2003. "Patents and new product development in the pharmaceutical and biotechnology industries," Proceedings, Federal Reserve Bank of Dallas, issue Sep, pages 87-104.
  16. C. Thomas Caskey, 2003. "The convergence of disruptive technologies enabling a new industrial approach to health products," Proceedings, Federal Reserve Bank of Dallas, issue Sep, pages 77-84.
  17. Frank R. Lichtenberg, 2003. "The benefits to society of new drugs: a survey of the econometric evidence," Proceedings, Federal Reserve Bank of Dallas, issue Sep, pages 43-59.
  18. Nicola Lacetera, 2003. "Incentives and spillovers in R&D activities: an agency-theoretic analysis of industry-university relations," Microeconomics 0312004, EconWPA.
  19. Malcolm Gillis, 2003. "Harnessing new technologies for the 21st century," Proceedings, Federal Reserve Bank of Dallas, issue Sep, pages 63-75.
  20. Rebecca S. Eisenberg, 2003. "Reaching through the genome," Proceedings, Federal Reserve Bank of Dallas, issue Sep, pages 105-115.
This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.